MULTIPLE DRUG RESISTANT PATHOGENS IN ACTION AFTER COVID PANDEMIC
DOI:
https://doi.org/10.55766/sujst-2023-06-e0930Keywords:
Antimicrobial Resistance, COVID, Staphylococcus aureusAbstract
The COVID-19 pandemic impacted the unique means for prompting the scientific community to consider developing healthcare infrastructures and logistics that will deal with any future pandemics, may be in a manner comparable to dealing with biological war or an outside attack due to Manmade weapons. Biomedical experts have refocused their efforts on creating innovative vaccines and medicines to halt the deadly spread of these infections using new biological approaches. Only a small number of innovative nations have a healthy security policy on national level in the event of a biological attack that has been bio-weaponized by a human. After the Covid pandemic, It is assumed that the whole world may have a fight against Multiple resistant bacterial pathogens or microorganisms connected to water and food. MDR bacteria (like MRSA and VRSA) in addition to newly mutated microorganism may also infect human beings, birds, and animals.
References
Alling, D.W., Blackwelder, W.C., and Stuart-Harris, C.H. (1981). A study of excess mortality during influenza epidemics in the United States, 1968-1976. American Journal of Epidemiology, 113(1):30-43. https://doi.org/10.1093/oxfordjournals.aje.a113063
Ameshe, A., Engda, T., and Gizachew, M. (2022). Antimicrobial Resistance Patterns, Extended-Spectrum Beta-Lactamase Production, and Associated Risk Factors of Klebsiella Species among UTI-Suspected Patients at Bahir Dar City, Northwest Ethiopia. International Journal of Microbiology, 18:8216545. https://doi.org/10.1155/2022/8216545
Attia, M.A., Essa, E.A., Elebyary, T.T., Faheem, A.M., and Elkordy, A.A. (2021). Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines. Pharmaceuticals, 14(11):1173. https://doi.org/10.3390/ph14111173
Bazaid, A.S., Barnawi, H., Qanash, H., Alsaif, G., Aldarhami, A., Gattan, H., Alharbi, B., Alrashidi, A., Al-Soud, W.A., Moussa, S., and Alfouzan, F. (2022). Bacterial Coinfection and Antibiotic Resistance Profiles among Hospitalised COVID-19 Patients. Microorganisms, 10(3):495. https://doi.org/10.3390/microorganisms10030495
Bikard, D., and Barrangou, R. (2017). Using CRISPR-Cas systems as antimicrobials. Current Opinion in Microbiology, 37:155-160. https://doi.org/10.1016/j.mib.2017.08.005
Blasco, B., Leroy, D., and Fidock, D.A. (2017). Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nature Medicine, 23(8):917-928. https://doi.org/10.1038/nm.4381
Chowdhury, A.M.M.A. and Uddin, K.N. (2022). Analysis of the Occurrence of Antibiotic Resistant Bacteria in the Hospital's Effluent and its Receiving Environment. Microbiol Insights, 14;15:11786361221078211. https://doi.org/10.1177/11786361221078211
Cobos, A.J., Nelson, C.G., Jehn, M., Viboud, C., and Chowell G. (2016). Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona. BMC Infectious Diseases, 16(1):405. https://doi.org/10.1186/s12879-016-1716-7
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V.A., Foster, S., Gilmore, B.F., Hancock, R.E., Harper, D., Henderson, I.R., Hilpert, K., Jones, B.V., Kadioglu, A., Knowles, D., Ólafsdóttir, S., Payne, D., Projan, S., Shaunak, S., Silverman, J., Thomas, C.M., Trust, T.J., Warn, P., and Rex, J.H. (2016). Alternatives to antibiotics-a pipeline portfolio review. Lancet Infectious Disease, 16(2):239-251. https://doi.org/10.1016/S1473-3099(15)00466-1
Gupta, R.K., George, R., and Nguyen-Van-Tam, J.S. (2008). Bacterial pneumonia and pandemic influenza planning. Emerging Infectious Diseases, 14(8):1,187-1,192. https://doi.org/10.3201/eid1407.070751
Hoelzer, K., Bielke, L., Blake, D.P., Cox, E., Cutting, S.M., Devriendt, B., Erlacher-Vindel, E., Goossens, E., Karaca, K., Lemiere, S., Metzner, M., Raicek, M., Collell-Suriñach, M., Wong, N.M., Gay, C., and Immerseel, F.V. (2018). Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs. Veterinary Research, 49(1):64. https://doi.org/10.1186/s13567-018-0560-8
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and Charpentier, E. (2012). A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science, 337(6096):816-21. https://doi.org/10.1126/science.1225829
Langford, B.J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D.R., Soucy, J.R., and Daneman, N. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infectious, 26(12):1,622-1,629. https://doi.org/10.1016/j.cmi.2020.07.016
Lansbury, L., Lim, B., Baskaran, V., and Lim, W.S. (2020). Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection, 81(2):266-275. https://doi.org/10.1016/j.jinf.2020.05.046
León-Buitimea, A., Balderas-Cisneros, F.J., Garza-Cárdenas, C.R., Garza-Cervantes, J.A., and Morones-Ramírez, J.R. (2022). Synthetic Biology Tools for Engineering Microbial Cells to Fight Superbugs. Frontiers in Bioengineering and Biotechnology, 4(10):869206. https://doi.org/10.3389/fbioe.2022.869206
Lewies, A., Du-Plessis, L.H., and Wentzel, J.F. (2019). Antimicrobial Peptides: the Achilles’ Heel of Antibiotic Resistance?. Probiotics and Antimicrobial Proteins, 11(2):370-381. https://doi.org/10.1007/s12602-018-9465-0
Moossavi, S., Miliku, K., Sepehri, S., Khafipour, E., and Azad, M.B. (2018). The Prebiotic and Probiotic Properties of Human Milk: Implications for Infant Immune Development and Pediatric Asthma. Frontiers in Pediatrics, 24(6):197. https://doi.org/10.3389/fped.2018.00197
Morens, D.M., Taubenberger, J.K., and Fauci, A.S. (2008). Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness. The Journal of infectious diseases, 198(7):962-970. https://doi.org/10.1086/591708
Pellagatti, A., Dolatshad, H., Valletta, S., and Boultwood, J. (2015). Application of CRISPR/Cas9 genome editing to the study and treatment of disease. Archives of Toxicology, 89(7):1,023-1,034. https://doi.org/10.1007/s00204-015-1504-y
Pitlik, S.D. (2020). COVID-19 Compared to Other Pandemic Diseases. Rambam Maimonides Medical Journal, 11(3):e0027. https://doi.org/10.5041/RMMJ.10418
Salazar, C.B., Spencer, P., Mohamad, K., Jabeen, A., Abdulmonem, W.A., and Fernández, N. (2022). Future pandemics might be caused by bacteria and not viruses: Recent advances in medical preventive practice. International journal of health sciences, 16(3):1-3. https://doi.org/10.53350/pjmhs22161827
Seal, B.S., Drider, D., Oakley, B.B., Brüssow, H., Bikard, D., and Rich, J.O., Miller, S., Devillard, E., Kwan, J., Bertin, G., Reeves, S., Swift, S.M., Raicek, M., and Gay, C.G. (2018). Microbial-derived products as potential new antimicrobials. Veterinary Research, 49:66. https://doi.org/10.1186/s13567-018-0563-5
Willyard, C. (2017). The drug-resistant bacteria that pose the greatest health threats. Nature, 543(7643):15. https://doi.org/10.1038/nature.2017.21550
Wu, Y., Battalapalli, D., Hakeem, M.J., Selamneni, V., Zhang, P., Draz, M.S., and Ruan, Z. (2021). Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. Journal of Nanobiotechnology, 19(1):401. https://doi.org/10.1186/s12951-021-01132-8
Zhou, P., Liu, Z., Chen, Y., Xiao, Y., Huang, X., and Fan, X. (2020). Bacterial and fungal infections in COVID-19 patients: A matter of concern. Infection Control & Hospital Epidemiology, 41(9):1,124-1,125. https://doi.org/10.1017/ice.2020.156
